The SLIT2/ROBO1 pathway has been shown to be involved in the progression of intrahepatic cholangiocarcinoma (ICC) [73], breast [74] and bowel cancer [75]. Here, SLIT2 is linked to intrahepatic cholangiocarcinoma.